Renova Therapeutics | Finanzwire

Basculer en Français

11311	Companies
251347	Keywords
180420	Articles
137166	Press releases

Home
Companies
Renova Therapeutics

BRIEF

published on 06/12/2024 at 15:05, 2 years 4 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
PRESS RELEASE

published on 06/12/2024 at 15:00, 2 years 4 months ago

Renova Therapeutics Announces Potential Expansion of Gene Therapy Platform for Heart Failure, Diabetes and Related Conditions
Renova Therapeutics announces exploration of new therapeutic opportunities expanding gene therapy use for diabetes and heart failure. Clinical trials and preclinical studies show promising results

Diabetes Clinical Trials Gene Therapy Renova Therapeutics Heart Failure
BRIEF

published on 05/09/2024 at 03:05, 2 years 6 months ago

Renova Therapeutics Prioritizes Gene Therapy Development for Heart Failure and Type 2 Diabetes

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Treatment Type 2 Diabetes Treatment
PRESS RELEASE

published on 05/09/2024 at 03:00, 2 years 6 months ago

Renova Therapeutics Announces Strategic Focus and Roadmap Prioritization for Its Gene Therapies to Treat Heart Failure and Type 2 Diabetes Mellitus
Renova Therapeutics prioritizes two primary regulatory pathways for launching pivotal human trials of gene therapies to treat heart failure and type 2 diabetes mellitus

Clinical Trials Gene Therapy Renova Therapeutics Heart Failure Type 2 Diabetes Mellitus

Accesswire

Published on 11/10/2026 at 14:45, 1 hour 16 minutes ago

An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 1 hour 30 minutes ago

First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 1 hour 31 minutes ago

Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 14:30, 1 hour 31 minutes ago

ACCESS Newswire Reports Third Quarter 2026 Results
Published on 11/10/2026 at 14:00, 2 hours 1 minute ago

Horizon Aircraft Completes Preliminary Design Review of Cavorite X7 Hybrid eVTOL

View all ACCESSWIRE

EQS Group

Published on 11/10/2026 at 15:10, 51 minutes ago

MICROIP Debuts at electronica 2026, Unveiling AI Drone and In-Vehicle Systems to Target European Edge AI Market
Published on 11/10/2026 at 15:05, 56 minutes ago

TEADIT® to break ground on Significant Facility Expansion
Published on 11/10/2026 at 15:05, 56 minutes ago

JOHNNIE WALKER AND SABRINA CARPENTER SHARE HER 'KEEP WALKING' STORY IN NEW FILM DIRECTED BY DAMIEN CHAZELLE
Published on 11/10/2026 at 14:55, 1 hour 6 minutes ago

Geely Farizon Launches 2027 Model Year SV in Germany, Bringing Integrated Passenger and Commercial Vehicle Services to Local Customers
Published on 11/10/2026 at 14:49, 1 hour 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.

Les Echos

Published on 11/10/2026 at 14:00, 2 hours ago

Guillemot Corporation S.A. | Weekly report share buyback from November 2 to November 6, 2026
Published on 11/10/2026 at 11:02, 4 hours 58 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 9 hours 1 minute ago

bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/09/2026 at 18:30, 21 hours 31 minutes ago

Air Liquide has successfully issued a CHF 390 million multi-tranche bond
Published on 11/09/2026 at 17:45, 22 hours 16 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE